Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

April 5, 2019

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions
Porphyrias, Hepatic
Trial Locations (2)

02-776

Institute of Hematology and Transfusion Medicine, Warsaw

04-628

National Institute of Cardiology, Warsaw

All Listed Sponsors
collaborator

Institute of Hematology and Transfusion Medicine, Warsaw

OTHER

lead

National Institute of Cardiology, Warsaw, Poland

OTHER

NCT05882136 - Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System | Biotech Hunter | Biotech Hunter